Els Van Nieuwenhuysen, Judith Michels, Hee Seung Kim, Víctor Moreno, Nicoletta Colombo, P. B. Ottevanger, Roisin Eilish O'Cearbhaill, Ruth Perets, An K.L Reyners, Suk-Young Yoo, Bin Wang, Jurriaan Brouwer, Mihaela C. Cristea, Nicole Costigan, Mary Jane Peterman, Brigid Barnes, Israel Lowy, Elizabeth Miller, Gloria S. Huang, Thomas S. Uldrick. "A phase 1/2 study of ubamatamab (REGN4018), a MUC16×CD3 bispecific antibody, administered alone or in combination with cemiplimab in a low-grade serous ovarian cancer cohort: Trial in progress.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5638